Weekly Digest – 03-09 Jun 2023 Weekly Digest – 03-09 Jun 2023 Jun 08, 2023: Keytruda / Chemo (IV) / Biliary Tract Cancer / Merck: The FDA accepted the sBLA application The FDA accepted the sBLA application for review based […]
Weekly Digest – 03-09 Jun 2023 Weekly Digest – 03-09 Jun 2023 Jun 06, 2023: Trodelvy (sacituzumab govitecan-hziy) / HR+/HER2- Metastatic Breast Cancer / Gilead Sciences: Reported encouraging Overall Survival benefits Gilead Science announced longer-term overall survival data from the […]
Weekly Digest – 03-09 Jun 2023 Weekly Digest – 03-09 Jun 2023 Jun 06, 2023: Tecartus / R/R Mantle Cell Lymphoma / Kite: Reported encouraging data Tecartus in patients with R/R MCL, showed consistently high complete response and overall response […]
Weekly Digest – 03-09 Jun 2023 Weekly Digest – 03-09 Jun 2023 Jun 05, 2023: Erdafitinib (IV) / Urothelial Cancer / Janssen: Improved Overall Survival Phase 3 THOR study met its primary endpoint of OS for Cohort 1 evaluating Erdafitinib […]
Weekly Digest – 03-09 Jun 2023 Weekly Digest – 03-09 Jun 2023 Jun 4, 2023: Nivolumab + Ipilimumab (oral) / NSCLC / BMS: Nivolumab + Ipilimumab along with chemo demonstrated durable, long-term survival in NSCLC patients At ASCO 2023, BMS […]
